Intelligence. Accountability. Analysis.
Est. 2022 · Washington, D.C.
The Congressional Times
We follow the data, not the narrative
◆ Live Intelligence
Loading...
Analysis Loading today's analysis...
Federal Policy

Children Hospitalized After Ingesting Suspected Psilocybin Edibles at New Jersey YMCA Camp

Children Hospitalized After Ingesting Suspected Psilocybin Edibles at New Jersey YMCA Camp

The incident raises questions about federal scheduling of psilocybin mushrooms under the Controlled Substances Act and the adequacy of state-level oversight at youth facilities.

Gab-E Intelligence Platform · July 25, 2026

More than a dozen children between the ages of 10 and 13 were hospitalized or rendered incapacitated after consuming suspected psilocybin-laced chocolate edibles at an East Orange YMCA summer camp in New Jersey on Thursday, July 24, 2026, according to reporting by the New York Post citing on-scene witness accounts. One child required hospitalization. A witness identified by the New York Post as Cynthia Cunningham, who arrived to retrieve her 12-year-old, described the affected children as appearing to be in a zombie-like state.

Psilocybin — the active compound in so-called 'magic mushrooms' — remains a Schedule I controlled substance under the federal Controlled Substances Act (21 U.S.C. § 812), meaning it is classified by the Drug Enforcement Administration as having no currently accepted medical use and a high potential for abuse. Possession and distribution carry significant federal criminal penalties under 21 U.S.C. § 841. The DEA's public scheduling database confirms this classification as of the date of publication.

At the federal legislative level, the issue of psilocybin has drawn congressional attention in recent sessions. The Breakthrough Therapies Act, introduced in prior Congresses, sought to facilitate clinical research pathways for Schedule I psychedelics; however, no legislation rescheduling psilocybin has been enacted as of July 25, 2026, per the Congressional Record and Congress.gov bill tracking. The FDA has granted psilocybin-assisted therapy 'Breakthrough Therapy' designation for treatment-resistant depression in clinical trial contexts, a status documented on the FDA's public database, but this designation does not alter its Schedule I status.

The East Orange, New Jersey incident falls under state jurisdiction for criminal investigation purposes, with federal involvement possible if interstate trafficking of the substance is established. The New Jersey Attorney General's office and local law enforcement jurisdiction — the East Orange Police Department — have not issued a formal public statement confirmed by official government records as of time of publication. The origin of the edibles and any chain of custody information have not been established in publicly available records.

What remains unknown: the identity of the individual or entity that introduced the edibles to the camp, whether charges have been filed, and the full medical status of all affected children. New Jersey court records, an official charging document from the Essex County Prosecutor's Office, and a formal incident report from East Orange police — all of which are public records under New Jersey's Open Public Records Act (N.J.S.A. 47:1A-1) — would answer these questions. The Congressional Times will update this report as official records become available.

Today's Analysis
Loading...
Latest Intelligence
Congressional Intelligence
Loading...
Financial Intelligence
Loading...
Geopolitical Intelligence
Loading...
Follow the MoneyGab-E Political Intelligence Investigation
Loading...
Opinion & Analysis
Loading...
Archive
Loading...
About
Our Mission

We Follow the Data, Not the Narrative

The Congressional Times exists because public records are public — and the analysis built from them should not be exclusive to those who can afford $60,000-a-year intelligence subscriptions.

Every story published in The Congressional Times is sourced to a verifiable public record: a court filing, a Senate lobbying disclosure, an FEC contribution record, a USASpending contract, or a verified news report. We state our sources inline. We show our math. When we are wrong, we say so publicly.

We do not editorialize in news coverage. We do not use loaded language. Both political parties are held to identical standards.

The Follow the Money investigations are the heart of this publication. Each begins with Gab-E Political Intelligence running against 10+ million government records before a single word of editorial is written.

Powered by Gab-E, an elite global intelligence platform built to democratize political and financial intelligence.

Editorial Policy
Editorial Standards & Corrections Policy

How We Source, Verify, and Correct Our Work

Every factual claim in a Congressional Times story is checked against a primary source: a government filing, a court record, a direct quote, before publication. When a claim can't be verified or doesn't hold up as originally reported, we drop it or reframe it. We do not publish disputed claims as settled fact.

When we get it wrong: we correct the story directly, note the correction and date at the bottom of the piece, and update the record. We do not quietly edit and move on.

Bylines: stories with a named byline are written and fact-checked by that person. Stories without a byline are sourced from Gab-E Political Intelligence, our automated research platform, and are labeled as such.

Ownership: The Congressional Times is published by Gab-E Holdings LLC. Gab-E, our intelligence platform, powers our sourcing and research pipeline.

Corrections or concerns: support@gab-e.com